Rauch G - Search Results

1

Optimization of the two-stage group sequential three-arm gold-standard design for non-inferiority trials.

Meis J, Pilz M, Herrmann C, Bokelmann B, Rauch G, Kieser M. Meis J, et al. Among authors: rauch g. Stat Med. 2023 Feb 20;42(4):536-558. doi: 10.1002/sim.9630. Epub 2022 Dec 28. Stat Med. 2023. PMID: 36577519

2

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study.

Nikoghosyan AV, Rauch G, Münter MW, Jensen AD, Combs SE, Kieser M, Debus J. Nikoghosyan AV, et al. Among authors: rauch g. BMC Cancer. 2010 Nov 5;10:606. doi: 10.1186/1471-2407-10-606. BMC Cancer. 2010. PMID: 21050498 Free PMC article. Clinical Trial.

3

Multiplicity adjustment for composite binary endpoints.

Rauch G, Kieser M. Rauch G, et al. Methods Inf Med. 2012;51(4):309-17. doi: 10.3414/ME11-01-0044. Epub 2012 Apr 24. Methods Inf Med. 2012. PMID: 22525969

4

Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.

Rauch G, Kieser M, Ulrich S, Doherty P, Rauch B, Schneider S, Riemer T, Senges J. Rauch G, et al. Among authors: rauch b. Eur J Prev Cardiol. 2014 Jan;21(1):74-80. doi: 10.1177/2047487312460518. Epub 2012 Sep 10. Eur J Prev Cardiol. 2014. PMID: 22964966

5

Opportunities and challenges of combined effect measures based on prioritized outcomes.

Rauch G, Jahn-Eimermacher A, Brannath W, Kieser M. Rauch G, et al. Stat Med. 2014 Mar 30;33(7):1104-20. doi: 10.1002/sim.6010. Epub 2013 Oct 13. Stat Med. 2014. PMID: 24122841

6

Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.

Schüler S, Mucha A, Doherty P, Kieser M, Rauch G. Schüler S, et al. Among authors: rauch g. Int J Cardiol. 2014 Jul 15;175(1):126-32. doi: 10.1016/j.ijcard.2014.04.267. Epub 2014 May 9. Int J Cardiol. 2014. PMID: 24861257

7

Opportunities and challenges of clinical trials in cardiology using composite primary endpoints.

Rauch G, Rauch B, Schüler S, Kieser M. Rauch G, et al. Among authors: rauch b. World J Cardiol. 2015 Jan 26;7(1):1-5. doi: 10.4330/wjc.v7.i1.1. World J Cardiol. 2015. PMID: 25632312 Free PMC article.

8

Two-stage designs for cross-over bioequivalence trials.

Kieser M, Rauch G. Kieser M, et al. Among authors: rauch g. Stat Med. 2015 Jul 20;34(16):2403-16. doi: 10.1002/sim.6487. Epub 2015 Mar 24. Stat Med. 2015. PMID: 25809815

9

Blinded sample size recalculation in clinical trials with binary composite endpoints.

Sander A, Rauch G, Kieser M. Sander A, et al. Among authors: rauch g. J Biopharm Stat. 2017;27(4):705-715. doi: 10.1080/10543406.2016.1198371. Epub 2016 Jun 13. J Biopharm Stat. 2017. PMID: 27295402

10

Choice of futility boundaries for group sequential designs with two endpoints.

Schüler S, Kieser M, Rauch G. Schüler S, et al. Among authors: rauch g. BMC Med Res Methodol. 2017 Aug 8;17(1):119. doi: 10.1186/s12874-017-0387-4. BMC Med Res Methodol. 2017. PMID: 28789615 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters